iADRS: Towards online adverse drug reaction analysis

SpringerPlus

Volumn 1, Issue 1, 2012, Pages 1-16

  Lin, Wen Yang ^a   Li, He Yi ^a   Du, Jhih Wei ^a   Feng, Wen Yu ^a   Lo, Chiao Feng ^a   Soo, Von Wun ^b  

^a NATIONAL UNIVERSITY OF KAOHSIUNG   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Adverse drug reaction; Associative classification; Contingency cube; Data mining; Data warehouse; Pharmacovigilance

Indexed keywords

EID: 84876424277     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-1-72     Document Type: Article

References (29)

1. AERS. (2012). Adverse Event Reporting System. http://www.fda.gov/cder/aers/default.htm.
2. Agrawal, R., & Srikant, R. (1994). Fast algorithms for mining association rules in large databases (In Proceedings of 20th International Conference on Very Large Data Bases, pp. 487-499).
3. Bate, A., & Evans, S. J. W. (2009). Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf, 18, 427-436.
4. Beta, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & de Freitas, R. M. (1998). A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol, 54(4), 315-321.
5. Beyer, K., & Ramakrishnan, R. (1999). Bottom-up computation of sparse and iceberg cubes. ACM SIGMOD Record, 28(2), 359-370.
6. Chaudhuri, S., & Dayal, U. (1997). An overview of data warehouse and OLAP technology. ACM SIGMOD Record, 26, 65-74.
7. Deshpande, G., Gogolak, V., & Smith, S. W. (2010). Data mining in drug safety: review of published threshold criteria for defining signals of disproportionate reporting. Pharmaceutical Medicine, 24(1), 37-43.
8. DrugDigest. (2012).: Drug Digest. http://www.drugdigest.org/wps/portal/ddigest.
9. Dumouchel, W. (1999). Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat, 53(3), 177-190.
10. EGBERTS, A. C., Meyboom, R. H., & van Puijenbroek, E. P. (2002). Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf, 25(6), 453-458.
11. Evans, S. J. W., Waller, P. C., & Davis, S. (2001). Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf, 10(6), 483-486.
12. Fram, D. M., Almenoff, J. S., & Dumouchel, W. (2003). Empirical bayesian data mining for discovering patterns in post-marketing drug safety (In Proceedings of the 9th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Washington DC, USA, pp. 359-368). New York, NY: ACM.
13. Han, J., Pei, J., & Yin, Y. (2000). Mining frequent patterns without candidate generation (In Proceedings of the 2000 ACM SIGMOD International Conference on Management of Data, pp. 1-12).
14. Huang, Y. T., Lin, S. F., Chiu, C. C., Yeh, H. Y., & Soo, V. W. (2007). Probability analysis on associations of adverse drug events with drug-drug interactions (In Proceedings of the 7th IEEE International Conference on Bioinformatics and Bioengineering, pp. 1308-1312). Boston, USA: IEEE Press.
15. Jin, H., Chen, J., He, H., Williams, G. J., Kelman, C., & O'Keefe, C. M. (2007). Mining unexpected temporal associations: applications in detecting adverse drug reactions. IEEE Trans Inf Technol Biomed, 12(4), 488-500.
16. Jin, H., Chen, J., He, H., Kelman, C., McAullay, D., & O'Keefe, C. M. (2010). Signaling potential adverse drug reactions from administrative health databases. IEEE Transactions on Knowledge and Data Engineering, 22(6), 839-853.
17. Kimball, R., Reeves, L., Ross, M., & Thornthwaite, W. (1998). The Data Warehouse Lifecycle Toolkit. New York, NY: John Wiley & Sons.
18. Li, W. M., Han, J. W., & Pei, J. (2001). CMAR: Accurate and efficient classification based on multiple class-association rules (In Proceedings of IEEE International Conference on Data Mining, pp. 369-376).
19. Lin, S. F., Xiao, K. T., Huang, Y. T., & Soo, V. W. (2009). A tool for finding possible explanations for adverse drug reactions through drug and drug target interactions. Artif Intell Med, 48(2-3), 161-166.
20. Orre, R., Lansner, A., Bate, A., & Lindquist, M. (2000). Bayesian neural networks with confidence estimations applied to data mining. Computational Statistics & Data Analysis, 34(4), 473-493.
21. Pedersen, T. B., & Jensen, C. S. (1998). Research issues in clinical data warehousing. In M. Rafanelli & M. Jarke (Eds.), In Proceedings of the 10th International Conference on Scientific and Statistical Database Management, Banff, Canada (pp. 43-52). Washington DC: IEEE Computer Society.
22. Piatetsky-Shapiro, G. (1991). Discovery, analysis, and presentation of strong rules. In G. Piatetsky-Shapiro & W. Frawley (Eds.), Knowledge Discovery in Databases (pp. 229-248). Cambridge, MA: AAAI/MIT Press.
23. PubMed. (2012).: PubMed. PubMed, http://www.ncbi.nlm.nih.gov/pubmed.
24. Roux, E., Thiessard, F., Fourrier, A., Bégaud, B., & Tubert-Bitter, P. (2005). Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Trans Inf Technol Biomed, 9(4), 518-527.
25. Szarfman, A., Machado, S. G., & O'Neill, R. T. (2002). Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf, 25(6), 381-392.
26. WHO. (1972). International Drug Monitoring: The Role of National Centres, WHO Technical Report No 498. Geneva: World Health Organization.
27. WHO. (2002). The Importance of Pharmacovigilance-Safety Monitoring of Medicinal Products. Geneva: World Health Organization.
28. Wongpoowarak, W., & Wongpoowarak, P. (2002). Unified algorithm for real-time detection of drug interaction and drug allergy. Comput Methods Programs Biomed, 68(1), 63-72.
29. 2 test. Suppl J R Stat Soc, 1(2), 217-235.